TASIGNA (nilotinib) Patient Assistance Program
Don’t let the high cost of brand specialty CML therapy disrupt your treatment. We help eligible patients access Tasigna (nilotinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Tasigna (nilotinib) is FDA-approved for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase, and for chronic or accelerated phase CML resistant to or intolerant of prior therapy including imatinib. It is a second-generation BCR-ABL tyrosine kinase inhibitor.
- Without assistance, brand Tasigna costs commonly run approximately $14,000–$16,500 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Tasigna for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic nilotinib is now available in the U.S. at substantially lower cost. Other CML TKIs include imatinib (Gleevec, generic), dasatinib (Sprycel, generic), bosutinib (Bosulif), ponatinib (Iclusig), and asciminib (Scemblix). Tasigna is uniquely associated with the possibility of treatment-free remission attempts in some long-term responders.
What Is Tasigna Prescription Assistance Program?
The Tasigna Prescription Assistance Program is a manufacturer-sponsored initiative that provides Tasigna at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for CML patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, oncology coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, brand Tasigna costs roughly $14,000–$16,500/month. Generic nilotinib is much cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$16,000 | Save ~$15,930/mo |
| CVS Pharmacy (brand) | ~$16,500 | Save ~$16,430/mo |
| Walmart (brand) | ~$14,500 | Save ~$14,430/mo |
| Costco (brand) | ~$14,200 | Save ~$14,130/mo |
Generic nilotinib | ~$4,000 | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Tasigna Prescription Program?
The Patient Assistance Program is free to apply for and provides Tasigna at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic nilotinib now available at lower cost, we’ll help you and your oncologist determine the best path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Tasigna:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $14,000–$16,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Tasigna assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Tasigna Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Tasigna:
Tasigna (nilotinib) is a twice-daily oral second-generation BCR-ABL tyrosine kinase inhibitor (TKI) used for Philadelphia chromosome-positive chronic myeloid leukemia (CML). It is more potent than imatinib and achieves faster, deeper molecular responses for many patients.
How Tasigna Works:
Chronic Myeloid Leukemia (CML) is driven by the BCR-ABL fusion gene, which creates an active tyrosine kinase that causes uncontrolled cell growth. Nilotinib is a second-generation tyrosine kinase inhibitor designed to be more potent and selective than older drugs like imatinib, achieving deeper and faster molecular responses. It binds directly to the BCR-ABL protein to shut down its harmful kinase activity. Patients who achieve a sustained, deep molecular response over several years may eventually become candidates for treatment-free remission under close medical monitoring.
Form and use:
Tasigna is an oral medication that must be taken twice daily on an empty stomach, specifically at least 2 hours after eating and 1 hour before the next meal. Taking it with food is dangerous because it significantly increases drug absorption to unsafe levels. The standard adult dose is 300 mg twice daily for newly diagnosed chronic phase CML, which increases to 400 mg twice daily for resistant or intolerant cases. Pediatric dosages differ from adult versions as they are calculated based on the patient’s body surface area.
Generic availability:
Generic nilotinib is currently available in the United States, offering a substantially lower-cost alternative to the brand-name Tasigna. Beyond nilotinib, there are several other tyrosine kinase inhibitors used to treat CML, including generic options like imatinib and dasatinib. Other specialized treatments in this drug class include bosutinib, ponatinib (which specifically targets the T315I mutation), and a novel STAMP inhibitor called asciminib.
Warnings:
Tasigna carries a boxed warning for QT prolongation and sudden death, making baseline and ongoing ECG monitoring mandatory alongside regular electrolyte corrections. Food must be strictly avoided during dosing hours because it spikes drug absorption and significantly increases these dangerous cardiac risks. The medication also requires close monitoring for myelosuppression, hepatotoxicity, pancreatitis, hyperglycemia, and tumor lysis syndrome at the start of therapy. Finally, it can cause severe arterial occlusive disease, ischemic heart disease, and embryo-fetal toxicity.
FAQ (Frequently Asked Questions)
How Much Does Tasigna Cost Without Insurance?
Brand Tasigna costs approximately $14,000–$16,500 per 30-day supply. Generic nilotinib is substantially cheaper. Through AffordMyPrescriptions, qualifying patients receive Tasigna at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Do I Need To Take Tasigna On An Empty Stomach?
Food significantly increases nilotinib absorption — taking Tasigna with food can dangerously raise drug levels and increase the risk of QT prolongation and sudden death (the boxed warning concern). Take Tasigna at least 2 hours after the previous meal and 1 hour before the next meal. Avoid grapefruit and grapefruit juice (which also raise nilotinib levels). This dosing requirement is essential — don’t skip it.
How Is Tasigna Different From Gleevec?
Both are BCR-ABL TKIs for CML. Tasigna (nilotinib) is a second-generation TKI — more potent, deeper molecular responses faster than imatinib (Gleevec). Tasigna is sometimes preferred for selected high-risk newly diagnosed patients who would benefit from deeper, faster responses. Trade-offs: Tasigna requires twice-daily dosing on an empty stomach and has QT prolongation and vascular event risks; Gleevec is once daily with food and has a longer safety track record. Many CML patients do excellently on either drug.
What Is Treatment-Free Remission?
Some CML patients who have been on Tasigna for many years and have achieved a sustained deep molecular response (MR4.5) for at least 1–2 years may be candidates for stopping nilotinib under careful monitoring — a ‘treatment-free remission’ (TFR) attempt. About 50% of carefully selected patients maintain molecular remission off TKI; the others require restarting therapy. TFR should only be attempted under expert oncology guidance with frequent molecular monitoring.
What Side Effects Should I Watch For?
Important side effects include cardiac/vascular events (chest pain, leg pain, sudden onset of severe headache, vision changes, signs of stroke — call 911), arrhythmias from QT prolongation, low blood counts (signs of infection, bleeding/bruising), elevated blood sugar (diabetes monitoring), elevated lipase/amylase (signs of pancreatitis), rash, headache. Tell your oncologist promptly about any new or worsening symptoms.
Are There Drug Interactions I Should Know About?
Yes — many. Nilotinib is metabolized by CYP3A and is itself a CYP3A inhibitor. Strong CYP3A inhibitors and inducers, antiarrhythmics, other QT-prolonging drugs (some antibiotics, antifungals, antidepressants, antipsychotics, antiemetics), proton pump inhibitors, antacids, statins, and warfarin can all interact significantly. Tell every prescriber and pharmacist about Tasigna.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic nilotinib (cheaper), generic imatinib (much cheaper, first-line for many patients), or another second-generation TKI like dasatinib (Sprycel, with generic), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Leukemia & Lymphoma Society, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Tasigna, our team may be able to help you access assistance programs designed to make brand specialty CML therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.